PE20070840A1 - Composiciones que comprenden enzimas para reducir el estres inmunologico - Google Patents
Composiciones que comprenden enzimas para reducir el estres inmunologicoInfo
- Publication number
- PE20070840A1 PE20070840A1 PE2006001615A PE2006001615A PE20070840A1 PE 20070840 A1 PE20070840 A1 PE 20070840A1 PE 2006001615 A PE2006001615 A PE 2006001615A PE 2006001615 A PE2006001615 A PE 2006001615A PE 20070840 A1 PE20070840 A1 PE 20070840A1
- Authority
- PE
- Peru
- Prior art keywords
- composition
- enzyme
- animal
- compositions including
- including enzymes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/244—Endo-1,3(4)-beta-glucanase (3.2.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/2488—Mannanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/2488—Mannanases
- C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01014—Chitinase (3.2.1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
REFERIDA A UNA COMPOSICION DE ADMINISTARCION ORAL QUE COMPRENDE UNA ENZIMA TAL COMO XILOGLUCANASA, ADNASA, NUCLEASA, N-GLUCANASA, CARBOHIDRASA, BETA-GLUCOSIDASA, QUITINASA, ARABINASA, ENTRE OTRAS. DICHA COMPOSICION PUEDE ESTAR BAJO LA FORMA DE UN ALIMENTO PARA ANIMALES, UNA COMPOSICION LIQUIDA QUE COMPRENDE 40.000 UI DE ENZIMA/L O UNA COMPOSICION SOLIDA QUE COMPRENDE 40.000 UI DE ENZIMA/KG. LA ENZIMA DE LA COMPOSICION REDUCE EL ESTRES INMUNOLOGICO EN UN ANIMAL DISMINUYENDO EL NIVEL DE PROTEINA DE FASE AGUDA POSITIVA EN DICHO ANIMAL, INCREMENTA EL NIVEL DE PROTEINA DE FASE AGUDA NEGATIVA Y/O MEJORA EL RENDIMIENTO DEL CRECIMIENTO DEL ANIMAL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75033905P | 2005-12-15 | 2005-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070840A1 true PE20070840A1 (es) | 2007-08-25 |
Family
ID=38218427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006001615A PE20070840A1 (es) | 2005-12-15 | 2006-12-15 | Composiciones que comprenden enzimas para reducir el estres inmunologico |
Country Status (35)
Country | Link |
---|---|
US (5) | US7914782B2 (es) |
EP (2) | EP2263685A3 (es) |
JP (1) | JP5189989B2 (es) |
KR (2) | KR101454032B1 (es) |
CN (3) | CN105831428B (es) |
AR (1) | AR057247A1 (es) |
AT (1) | ATE497779T1 (es) |
AU (1) | AU2006329927B2 (es) |
BR (1) | BRPI0620155B1 (es) |
CA (1) | CA2633066C (es) |
CL (1) | CL2011000941A1 (es) |
CR (1) | CR10116A (es) |
DE (1) | DE602006020074D1 (es) |
DK (1) | DK1973561T3 (es) |
EC (1) | ECSP088578A (es) |
ES (1) | ES2361819T3 (es) |
GT (1) | GT200600512A (es) |
HN (1) | HN2008000906A (es) |
HR (1) | HRP20080319B1 (es) |
IL (2) | IL192088A (es) |
IN (1) | IN2008DE06112A (es) |
MX (1) | MX284326B (es) |
MY (1) | MY145870A (es) |
NO (1) | NO340818B1 (es) |
NZ (1) | NZ569186A (es) |
PE (1) | PE20070840A1 (es) |
PL (1) | PL1973561T3 (es) |
PT (1) | PT1973561E (es) |
RU (1) | RU2465005C2 (es) |
SI (1) | SI1973561T1 (es) |
SV (1) | SV2008002942A (es) |
TW (2) | TWI619506B (es) |
UA (1) | UA95266C2 (es) |
WO (1) | WO2007075343A2 (es) |
ZA (1) | ZA200805780B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006329927B2 (en) * | 2005-12-15 | 2011-09-29 | Elanco Us Inc. | Enzymes for reduced immunological stress |
PT2814331T (pt) * | 2012-02-16 | 2019-02-12 | Elanco Us Inc | Métodos e composições para redução do impacto ambiental de resíduos animais |
WO2015011276A1 (en) * | 2013-07-26 | 2015-01-29 | Novozymes A/S | POLYPEPTIDES HAVING α-L-GALACTOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME |
WO2015140318A1 (en) * | 2014-03-21 | 2015-09-24 | Dsm Ip Assets B.V. | Process for the treatment of yeast cell walls with a laminaripentaose producing beta-1,3-glucanase |
CN106771257A (zh) * | 2017-01-24 | 2017-05-31 | 北京美正生物科技有限公司 | 一种检测血清淀粉样蛋白a的酶联免疫吸附试剂盒及其制备方法和用途 |
CN107156522A (zh) * | 2017-06-23 | 2017-09-15 | 都匀市山郎科技养殖有限公司 | 一种鸡饲料 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58201949A (ja) * | 1982-05-17 | 1983-11-25 | Kyodo Shiryo Kk | 家畜用配合飼料 |
US5372939A (en) * | 1991-03-21 | 1994-12-13 | The United States Of America As Represented By The United States Department Of Energy | Combined enzyme mediated fermentation of cellulous and xylose to ethanol by Schizosaccharoyces pombe, cellulase, β-glucosidase, and xylose isomerase |
JP2942384B2 (ja) * | 1991-06-07 | 1999-08-30 | 株式会社ヤクルト本社 | 飼料効率改善添加剤 |
GB2261877A (en) * | 1991-11-21 | 1993-06-02 | Kyowa Hakko Kogyo Kk | Animal feed additive comprising enzyme and amino acid |
AU4835693A (en) * | 1993-08-13 | 1995-03-14 | Rijksuniversiteit Te Groningen | Pharmaceutical composition comprising phosphatase or a derivative thereof |
US5861271A (en) | 1993-12-17 | 1999-01-19 | Fowler; Timothy | Cellulase enzymes and systems for their expressions |
CA2188542C (en) * | 1994-04-22 | 2008-08-19 | Per Munk Nielsen | A method for improving the solubility of vegetable proteins |
GB9416841D0 (en) * | 1994-08-19 | 1994-10-12 | Finnfeeds Int Ltd | An enzyme feed additive and animal feed including it |
MY134684A (en) | 1995-05-15 | 2007-12-31 | Gist Brocades Bv | Application of phospholipases in animal feed |
JP2001057852A (ja) * | 1995-06-14 | 2001-03-06 | Showa Denko Kk | 耐熱酵素含有飼料用組成物 |
US5807694A (en) * | 1995-09-07 | 1998-09-15 | Economic Innovation And Technology Council, University Of Manitoba | Detection of salmonella enteritidis and other pathogenic microorganisms and monoclonal antibody useful therefor |
WO1997016982A1 (en) * | 1995-11-06 | 1997-05-15 | Novo Nordisk A/S | Animal feed additives |
AU2568697A (en) * | 1996-04-12 | 1997-11-07 | Novo Nordisk A/S | An enzyme with beta-1,3-glucanase activity |
US6162473A (en) | 1996-05-03 | 2000-12-19 | Chemgen Corporation | Hemicellulase use in feeds with low caloric content |
CN1092495C (zh) | 1996-05-03 | 2002-10-16 | 开姆根有限公司 | 半纤维素酶在低热焓饲料中的应用 |
US20020164751A1 (en) * | 1996-06-19 | 2002-11-07 | Short Jay M. | Enzymes having thermostable phosphatase activity and methods of use thereof |
GB9623539D0 (en) | 1996-11-12 | 1997-01-08 | Biotal Ltd | Enzymes and their use |
GB2327345B (en) * | 1997-07-18 | 1999-06-23 | Finnfeeds Int Ltd | Use of an enzyme for manufacturing an agent for controlling bacterial infection |
US6022566A (en) * | 1997-12-02 | 2000-02-08 | Balchem Corporation | Method for increasing the feed intake, feed efficiency, daily gain and/or carcass grade in ruminants |
EP0976838A1 (en) * | 1998-05-06 | 2000-02-02 | Rhone-Poulenc Nutrition Animale | Enzymes mixture |
US6331426B1 (en) * | 1999-02-11 | 2001-12-18 | Novozymes A/S | Bacterial galactanases and use thereof |
US6213930B1 (en) | 1999-03-15 | 2001-04-10 | Wisconsin Alumni Research Foundation | Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency |
US6500658B1 (en) * | 1999-08-17 | 2002-12-31 | Novozymes, A/S | Xyloglucanase from Malbranchea |
UA78486C2 (uk) * | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти) |
GB0010748D0 (en) | 2000-05-05 | 2000-06-28 | Brown Paul D | Tricep exercise horse (fold up and portable) |
US20020095135A1 (en) * | 2000-06-19 | 2002-07-18 | David Meeker | Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
GB2371013B (en) | 2001-01-16 | 2004-06-09 | Terry John Claydon | Copying apparatus |
IL157006A0 (en) * | 2001-01-17 | 2004-02-08 | Univ Ramot | Chitinases, derived from carnivorous plants, polynucleotide sequence encoding thereof, and methods of isolating and using same |
DE10105306A1 (de) * | 2001-02-02 | 2002-08-22 | Nutrinova Gmbh | Futtermittel für die Nutztieraufzucht enthaltend Sorbinsäure und Enzyme |
DE10105347A1 (de) * | 2001-02-05 | 2002-08-22 | Nutrinova Gmbh | Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht |
IE20011100A1 (en) * | 2001-12-21 | 2003-07-09 | Vsl Pharma Ltd | Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method |
WO2003062409A2 (en) | 2002-01-25 | 2003-07-31 | Dsm Ip Assets B.V. | Thermostable enzyme compositions |
WO2005000195A2 (en) * | 2002-11-13 | 2005-01-06 | Rosenberg Yvonne J | A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
EP1572230B1 (en) * | 2002-12-12 | 2010-09-08 | Zoltan Laboratories | Placental alkaline phosphatase to control diabetes |
CA2554683C (en) * | 2004-02-04 | 2014-06-10 | Pharmaaware Sepsis B.V. | Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers |
US20110142817A1 (en) * | 2004-02-04 | 2011-06-16 | Pharmaaware Sepsis B.V. | Means and method for treating and/or preventing necrotizing enterocolitis |
PL1740204T3 (pl) * | 2004-04-01 | 2018-08-31 | Chiesi Farmaceutici S.P.A. | Lecznicze zastosowanie alfa-mannozydazy |
WO2006099699A1 (en) * | 2005-03-25 | 2006-09-28 | Universiteit Gent | Enzymatic demethylation of flavonoids |
CN1699576A (zh) * | 2005-06-30 | 2005-11-23 | 江南大学 | 一种内切β-1,3葡聚糖酶基因及其克隆方法 |
US7589083B2 (en) * | 2005-09-12 | 2009-09-15 | Cancure Laboratories, Llc | Compounds and compositions to control abnormal cell growth |
AU2006329927B2 (en) * | 2005-12-15 | 2011-09-29 | Elanco Us Inc. | Enzymes for reduced immunological stress |
ES2421717T3 (es) * | 2008-02-29 | 2013-09-05 | Alloksys Life Science B V | Fosfatasa alcalina para aumentar la actividad del sistema inmune en un mamífero con riesgo de enfermedades inflamatorias |
-
2006
- 2006-12-14 AU AU2006329927A patent/AU2006329927B2/en active Active
- 2006-12-14 US US11/610,572 patent/US7914782B2/en active Active
- 2006-12-14 CA CA2633066A patent/CA2633066C/en active Active
- 2006-12-14 ES ES06848883T patent/ES2361819T3/es active Active
- 2006-12-14 PL PL06848883T patent/PL1973561T3/pl unknown
- 2006-12-14 KR KR1020087017119A patent/KR101454032B1/ko active IP Right Grant
- 2006-12-14 BR BRPI0620155-5A patent/BRPI0620155B1/pt active IP Right Grant
- 2006-12-14 GT GT200600512A patent/GT200600512A/es unknown
- 2006-12-14 EP EP10161087A patent/EP2263685A3/en not_active Withdrawn
- 2006-12-14 MY MYPI20082117A patent/MY145870A/en unknown
- 2006-12-14 NZ NZ569186A patent/NZ569186A/en unknown
- 2006-12-14 KR KR1020137016367A patent/KR101399205B1/ko active IP Right Grant
- 2006-12-14 RU RU2008128583/15A patent/RU2465005C2/ru active
- 2006-12-14 WO PCT/US2006/047592 patent/WO2007075343A2/en active Application Filing
- 2006-12-14 JP JP2008545775A patent/JP5189989B2/ja active Active
- 2006-12-14 UA UAA200808786A patent/UA95266C2/uk unknown
- 2006-12-14 SI SI200630980T patent/SI1973561T1/sl unknown
- 2006-12-14 DK DK06848883.2T patent/DK1973561T3/da active
- 2006-12-14 CN CN201610203760.1A patent/CN105831428B/zh active Active
- 2006-12-14 DE DE602006020074T patent/DE602006020074D1/de active Active
- 2006-12-14 CN CN2011101968711A patent/CN102293323A/zh active Pending
- 2006-12-14 PT PT06848883T patent/PT1973561E/pt unknown
- 2006-12-14 CN CN200680052912.7A patent/CN101374544B/zh active Active
- 2006-12-14 AT AT06848883T patent/ATE497779T1/de active
- 2006-12-14 EP EP06848883A patent/EP1973561B1/en active Active
- 2006-12-15 TW TW102115171A patent/TWI619506B/zh active
- 2006-12-15 AR ARP060105545A patent/AR057247A1/es active IP Right Grant
- 2006-12-15 PE PE2006001615A patent/PE20070840A1/es not_active Application Discontinuation
- 2006-12-15 TW TW095147220A patent/TWI402039B/zh active
-
2008
- 2008-06-12 IL IL192088A patent/IL192088A/en active IP Right Grant
- 2008-06-13 HN HN2008000906A patent/HN2008000906A/es unknown
- 2008-06-13 SV SV2008002942A patent/SV2008002942A/es unknown
- 2008-06-13 MX MX2008007735A patent/MX284326B/es active IP Right Grant
- 2008-06-19 ZA ZA200805780A patent/ZA200805780B/xx unknown
- 2008-06-23 EC EC2008008578A patent/ECSP088578A/es unknown
- 2008-06-26 CR CR10116A patent/CR10116A/es unknown
- 2008-07-02 HR HRP20080319AA patent/HRP20080319B1/hr not_active IP Right Cessation
- 2008-07-09 NO NO20083035A patent/NO340818B1/no unknown
- 2008-07-11 IN IN6112DE2008 patent/IN2008DE06112A/en unknown
-
2011
- 2011-03-25 US US13/072,123 patent/US8778648B2/en active Active
- 2011-03-25 US US13/072,109 patent/US20110171344A1/en not_active Abandoned
- 2011-03-25 US US13/072,131 patent/US20110177195A1/en not_active Abandoned
- 2011-04-27 CL CL2011000941A patent/CL2011000941A1/es unknown
-
2013
- 2013-07-04 IL IL227318A patent/IL227318A/en active IP Right Grant
-
2017
- 2017-02-17 US US15/436,404 patent/US20170156371A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR124140A2 (es) | Formulaciones de anticuerpos | |
CL2016001553A1 (es) | Medios para cultivo celular | |
MX2010009850A (es) | Analogos de insulina acilados y etabilizados contra proteasas. | |
PE20070840A1 (es) | Composiciones que comprenden enzimas para reducir el estres inmunologico | |
CL2011003078A1 (es) | Uso de una composicion nutricional para mantener, sostener y/o mejorar el desempeno cognitivo en un nino de 3 a 6 anos, que comprende al menos una fuente de proteina, una fuente de carbohidratos, una fuente de lipido, un microorganismo probiotico, y prebioticos, en donde la fuente de lipido comprende acido docosahexanoico (dha). | |
MX2021015825A (es) | Formulaciones de anticuerpos estables acuosas. | |
AR053803A1 (es) | Uso de acido pinolenico | |
AR056816A1 (es) | Composicion con ácido docosapentenoico | |
BRPI0813237B8 (pt) | composto, método para preparar o composto, medicamento, e, uso do composto | |
TW200745103A (en) | Substituted 7-azaindazoles, compositions containing them, production process and use | |
NZ717728A (en) | Stable formulations of a hyaluronan-degrading enzyme | |
EA200701172A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение | |
ZA201908610B (en) | Il-15 protein complex pharmaceutical composition and uses thereof | |
EA201890075A1 (ru) | Инъецируемые фармацевтические композиции лефамулина | |
MX2017009929A (es) | Composiciones y métodos para metabolismo muscular mejorado. | |
WO2013006766A3 (en) | Formulations that stabilize proteins | |
ECSP17012504A (es) | Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones | |
ATE541855T1 (de) | Weitere kristalline formen von rostafuroxin | |
TW200712129A (en) | Silicone material having outstanding viscosity stability | |
AR077679A1 (es) | Producto alimenticio que comprende una capa reductora de migracion de humedad | |
CZ2014676A3 (cs) | Aplikační směs pro zvýšení účinnosti antiseptik a/nebo dezinficiens, aplikační prostředek obsahující aplikační směs, a použití této směsi | |
JP1756431S (ja) | 水筒 | |
DOP2019000207A (es) | Composición líquida que contiene pradofloxacina | |
EA202191673A1 (ru) | Композиция на основе клеток, содержащая клетки-предшественники печени, экспрессирующие hla-e | |
CL2008001778A1 (es) | Formulacion liofilizada estable que comprende natalizumab, bufer con un ph entre 5,5 a 6,5, sacarosa y polisorbato; formulacion reconstituida estable; y metodo de preparacion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |